Luteolin Reduced the Traumatic Brain Injury-Induced Memory Impairments in Rats: Attenuating Oxidative Stress and Dark Neurons of Hippocampus
Traumatic Brain Injury (TBI) is generally recognized as a major risk factor for memory impairments and Alzheimer’s disease (AD). In this experimental study, our aim was to investigate the ameliorating effects of luteolin (LUT) on the memory impairments, oxidative stress, and histopathological changes induced by TBI in rats. The adult male Wistar rats were randomly divided into six groups including: Control (Co), sham, TBI, TBI+LUT (10 mg/kg), TBI +LUT (25 mg/kg), TBI +LUT (50 mg/kg). To evaluate the protective effects of LUT on the memory of the rats, passive avoidance test using shuttle box was performed. Finally, the animals were anesthetized, and the brain tissues were removed and analyzed for oxidative stress parameters. Using histological methods, dark neuron production was also evaluated. There was a significant decrease in the latency time to enter the dark compartment in passive avoidance test in TBI animals. This latency time was significantly increased in TBI+LUT (25 mg/kg) and TBI+LUT (50 mg/kg) groups along with significant increases in superoxide dismutase and catalase activity in the hippocampal zone and a decrease in malondialdehyde (MDA). The number of dark neurons in the hippocampus decreased with all three doses of LUT. In the present study, LUT showed neuroprotective effects, improvement in learning and reduction in memory impairment induced by TBI in rats. Protection against oxidative stress might be a possible mechanism behind these effects. Further works are necessary to work out if LUT is potentially a suitable therapeutic candidate for neural disorders.
Williams AL. Traumatic brain injury. Physical Management for Neurological Conditions E-Book. 2018:p153.
Zohar O, Lavy R, Zi X, Nelson TJ, Hongpaisan J, Pick CG, et al. PKC activator therapeutic for mild traumatic brain injury in mice. Neurobiol Dis 2011 Feb;41(2):329-37.
Comper P, Bisschop S, Carnide N, Tricco A. A systematic review of treatments for mild traumatic brain injury. Brain Inj 2005 Oct;19(11):863-80.
Girgis F, Pace J, Sweet J, Miller JP. Hippocampal neurophysiologic changes after mild traumatic brain injury and potential neuromodulation treatment approaches. Front Syst Neurosci 2016;10:8.
Aligholi H, Rezayat SM, Azari H, Mehr SE, Akbari M, Mousavi SMM, et al. Preparing neural stem/progenitor cells in PuraMatrix hydrogel for transplantation after brain injury in rats: A comparative methodological study. Brain Res 2016;1642:197-208.
Lowenstein DH, Thomas MJ, Smith DH, McIntosh TK. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci 1992;12(12):4846-53.
Guo Z, Cupples LA, Kurz A, Auerbach SH, Volicer L, Chui H, et al. Head injury and the risk of AD in the MIRAGE study. Neurology 2000 Mar 28;54(6):1316-23.
Bains M, Hall ED. Antioxidant therapies in traumatic brain and spinal cord injury. Biochim Biophys Acta 2012 May;1822(5):675-84.
Xu J, Wang H, Ding K, Zhang L, Wang C, Li T, et al. Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2–ARE pathway.Free Radic Biol Med2014 Jun;71:186-95.
Liu Y, Fu X, Lan N, Li S, Zhang J, Wang S, et al. Luteolin protects against high fat diet-induced cognitive deficits in obesity mice. Behav Brain Res 2014 Jul 1;267:178-88.
Mahakizadeh S, Akbari M, Sharifzadeh M, Rastegar T, Abolhassani F, Hassanzadeh G. Wharton’jelly mesenchymal stem cells and insulin effect on BDNF expression in CA1 and CA3 regions of rats’ hippocampus after chronic hypoxia. J Contem Med Sci.2018;4(2):63-9.
Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004;3(3):205-14.
Loh KP, Qi J, Tan BKH, Liu XH, Wei BG, Zhu YZ. Leonurine protects middle cerebral artery occluded rats through antioxidant effect and regulation of mitochondrial function. Stroke 2010;41(11):2661-8.
Bazrafkan M, Nikmehr B, Shahverdi A, Hosseini SR, Hassani F, Poorhassan M, et al. Lipid peroxidation and its role in the expression of NLRP1a and NLRP3 genes in testicular tissue of male rats: A model of spinal cord injury. Iran Biomed J 2018;22(3):151.
Guhr G, Lachance PA. Role of phytochemicals in chronic disease prevention. Nutraceuticals: Designer foods III garlic, soy, and licorice. 1997:311-64.
Bagheri A, Talei S, Hassanzadeh N, Mokhtari T, Akbari M, Malek F, et al. The neuroprotective effects of flaxseed oil supplementation on functional motor recovery in a model of ischemic brain stroke: Upregulation of BDNF and GDNF. Acta Med Iran 2018;55(12):785-92.
Mokhtari T, Faghir Ghanesefat H, Hassanzadeh G, Moayeri A, Jafar Haeri SM, Rezaee Kanavee A, et al. Effects of Flaxseed oil supplementation on renal dysfunction due to ischemia/reperfusion in rat. JBRMS 2017;4(1):22-9.
Zeng L-h, Zhang H-d, Xu C-j, Bian Y-j, Xu X-j, Xie Q-m, et al. Neuroprotective effects of flavonoids extracted from licorice on kainate-induced seizure in mice through their antioxidant properties. J Zhejiang Univ Sci B 2013;14(11):1004-12.
Thilakarathna SH, Rupasinghe H. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 2013;5(9):3367-87.
Beking K, Vieira A. Flavonoid intake and disability-adjusted life years due to Alzheimer’s and related dementias: Public Health Nutr 2010;13(9):1403-9.
Tian X, Sun L, Gou L, Ling X, Feng Y, Wang L, et al. Protective effect of l-theanine on chronic restraint stress-induced cognitive impairments in mice. Brain Res 2013;1503:24-32.
Marmarou A, Foda MAA-E, Brink Wvd, Campbell J, Kita H, Demetriadou K. A new model of diffuse brain injury in rats: Part I: Pathophysiology and biomechanics. J Neurosurg 1994;80(2):291-300.
Khaksari M, Razmi Z, Hekmat AS, Naderi V, Rostami S. The effects of cyclooxygenase inhibitors on the brain inflammatory response following traumatic brain injury in rats. Iran J Basic Med Sci 2012;15(5):1102.
Keshavarzi Z, Khaksari M, Gholamreza A. The Effects of Female Sexual Hormones and Estrogen Receptor Agonists on The NF-κB p50 and p65 Levels Following TBI in Rat Intestine. Journal of Neurological Sciences (Turkish). 2012;29(3).
Sarkaki A, Rezaiei M. Improving active and passive avoidance memories deficits due to permanent cerebral ischemia by pomegranate seed extract in female rats. Malays J Med Sci 2013;20(2):25.
Salmani H, Hosseini M, Beheshti F, Baghcheghi Y, Sadeghnia HR, Soukhtanloo M, et al. Angiotensin receptor blocker, losartan ameliorates neuroinflammation and behavioral consequences of lipopolysaccharide injection. Life Sci 2018;203:161-70.
Mokhtari T, Akbari M, Malek F, Kashani IR, Rastegar T, Noorbakhsh F, et al. Improvement of memory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region. Daru 2017;25(1):4.
Amiri S, Yousefi-Ahmadipour A, Hosseini M-J, Haj-Mirzaian A, Momeny M, Hosseini-Chegeni H, et al. Maternal exposure to silver nanoparticles are associated with behavioral abnormalities in adulthood: Role of mitochondria and innate immunity in developmental toxicity. Neurotoxicology 2018;66:66-77.
Bideskan ARE, Ataei ML, Mansouri S, Hosseini M. The effects of tamoxifen and soy on dark neuron production in hippocampal formation after pentylenetetrazole-induced repeated seizures in rats. Pathophysiology 2015;22(2):125-35.
Ooigawa H, Nawashiro H, Fukui S, Otani N, Osumi A, Toyooka T, et al. The fate of Nissl-stained dark neurons following traumatic brain injury in rats: difference between neocortex and hippocampus regarding survival rate. Acta Neuropathol 2006;112(4):471-81.
Salkovic-Petrisic M, Hoyer S. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl 2007. p. 217-33.
Cornelius C, Crupi R, Calabrese V, Graziano A, Milone P, Pennisi G, et al. Traumatic brain injury: oxidative stress and neuroprotection. Antioxidants & redox signaling. 2013;19(8):836-53.
Varadarajan S, Yatin S, Kanski J, Jahanshahi F, Butterfield DA. Methionine residue 35 is important in amyloid β-peptide-associated free radical oxidative stress. Brain Res Bull 1999;50(2):133-41.
Ezaki J, Shimada R, Shibuya M, Kibayashi K. Hippocampal neuronal degeneration in the traumatic brain injury mouse: non-trivial effect of scalp incision. Neurol Res 2016;38(11):994-1002.
Eghwrudjakpor P, Allison A. Oxidative stress following traumatic brain injury: enhancement of endogenous antioxidant defence systems and the promise of improved outcome. Niger J Med 2010;19(1).
Ashaari Z, Hassanzadeh G, Alizamir T, Yousefi B, Keshavarzi Z, Mokhtari T. The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review. J Mol Neurosci 2018:1-16.
Xia F, Wang C, Jin Y, Liu Q, Meng Q, Liu K, et al. Luteolin protects HUVECs from TNF-α-induced oxidative stress and inflammation via its effects on the Nox4/ROS-NF-κB and MAPK pathways. J Atheroscler Thromb 2014;21(8):768-83.
Sawmiller D, Li S, Shahaduzzaman M, Smith AJ, Obregon D, Giunta B, et al. Luteolin Reduces Alzheimer’s Disease Pathologies Induced by Traumatic Brain Injury. Int J Mol Sci. 2014;15(1):895-904.
Liu Y, Tian X, Gou L, Sun L, Ling X, Yin X. Luteolin attenuates diabetes-associated cognitive decline in rats. Brain Res Bull 2013;94:23-9.
Choi S-M, Kim BC, Cho Y-H, Choi K-H, Chang J, Park M-S, et al. Effects of flavonoid compounds on β-amyloid-peptide-induced neuronal death in cultured mouse cortical neurons. Chonnam Med J 2014;50(2):45-51.
Qiao H, Dong L, Zhang X, Zhu C, Zhang X, Wang L, et al. Protective effect of luteolin in experimental ischemic stroke: upregulated SOD1, CAT, Bcl-2 and claudin-5, down-regulated MDA and Bax expression. Neurochem Res 2012;37(9):2014-24.
Zhao G, Qin G-W, Wang J, Chu W-J, Guo L-H. Functional activation of monoamine transporters by luteolin and apigenin isolated from the fruit of Perilla frutescens (L.) Britt. Neurochem Int 2010;56(1):168-76.